Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is an age-related disease with no cure. Mesenchymal stem cell (MSC)-based therapy has emerged as a novel strategy for IPF treatment. Nevertheless, MSCs derived from patients with IPF (IPF-MSCs) become senescent, thereby reducing their beneficial effect...

全面介紹

Na minha lista:
書目詳細資料
發表在:Stem Cell Res Ther
Main Authors: Shi, Linli, Han, Qian, Hong, Yimei, Li, Weifeng, Gong, Gencheng, Cui, Jiangyu, Mao, Mengmeng, Liang, Xiaoting, Hu, Bei, Li, Xin, Luo, Qun, Zhang, Yuelin
格式: Artigo
語言:Inglês
出版: BioMed Central 2021
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7905557/
https://ncbi.nlm.nih.gov/pubmed/33632305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-021-02215-x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍